Outcome of Manifestation and sign of pneumonia in children under five years of age
DOI:
https://doi.org/10.70765/28grfk04Keywords:
pneumonia, education, health, presentation, Kohat , age.Abstract
Objective: Acute infectious diseases such as pneumonia can be brought on by bacteria, viruses, or fungi and harm the lung parenchyma. It continues to be the world's top cause of death for children under five. Immunizations, a balanced diet, and a reduction in environmental stressors can all help with prevention. Early discovery, appropriate care, and prompt hospital admission are essential for treating this illness with low-tech, accessible therapies.
Methods: With ethical consent, a case series study was carried out in the pediatric department of District Kohat Hospital from August 2023 to February 2024. Informed consent was obtained from the parents of 139 study participants. SPSS version 24 was used for the data analysis process.
Results: Lethargy was the most prevalent clinical symptom (23.74%), while cyanosis was the least common (2.87%). Men experienced greater effects than women (59% vs. 41%). The vaccination rate for the first dosage was the lowest (28%) and the non-vaccination rate was the highest (44%).
Conclusion: Health planners must emphasize filling in the gaps in the EPI schedule by using media like radio, television, and newspapers.
Downloads
References
1: Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY, Kim Y, Kim S, Park C, Seo JH, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20(1):132. DOI: https://doi.org/10.1186/s12879-020-4810-9
2: Kuo CY, Tsai WC, Lee HF, Ho TS, Huang LM, Shen CF, Liu CC. The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019–2020. J Microbiol Immunol Infect. 2022;55(4):611–9. DOI: https://doi.org/10.1016/j.jmii.2021.09.010
3: Na R, Si P, Zhang J, Zheng L, Shen Y. Prevalence of Mycoplasma pneumoniae respiratory tract infection in children and its relationship with environmental factors in Tianjin from 2015 to 2019. Maternal Child Health Care of China. 2021;36(19):4496–8.
4: Song Y, Zhao R, Dong X. Epidemiological characteristics of Mycoplasma pneumoniae infection in children in Taiyuan from 2011 to 2018. Chin Remedies Clin. 2020;20(07):1083–4.
5: Akramova H., Alieva N., Turdieva D. (2023). Level of neurotropic autoantibodies in newborns. Current issues in practical pediatrics, 1(1), 23-25.
6: Comparative analysis of peculiarities of adaptation of babies K Akramova, D Turdieva, D Akhmedova
Journal of Advanced Research in Dynamical and Control Systems 12 (2), 2020, P.2735-2740
7: Goryachko A.N., Sukalo A.V. A prognostic model for determining the likelihood of developing congenital pneumonia in full-term newborns // Child Health. -2019.-No. 4 (14). -P.256-261. DOI: https://doi.org/10.22141/2224-0551.14.4.2019.174040
8: Tsarkova S.A., Abdullaev A.N., Surovtseva D.A., Pomazkina A.V. X-ray negative pneumonia in young children - a real phenomenon or a diagnostic error? Russian pediatric journal. 2020; 1(2): 31-37. doi: 10.15690/rpj.v1i2.2091 DOI: https://doi.org/10.15690/rpj.v1i2.2091
9: World Health Organization. Media center fact sheets on pneumonia. Available from: https://www.who.int/mediacentre/factsheets/fs331/en [Last accessed on 2022 Nov 19]
10: Iuliano A, Aranda Z, Colbourn T, Agwai IC, Bahiru S, Bakare AA, et al. The Burden and risks of pediatric pneumonia in Nigeria: A desk-based review of existing literature and data. Pediatr Pulmonol. 2020;55(Suppl 1):S10-21. DOI: https://doi.org/10.1002/ppul.24626
11: Kazi S, Hernstadt H, Abo YN, Graham H, Palmer M, Graham SM, et al. The utility of chest x-ray and lung ultrasound in the management of infants and children presenting with severe pneumonia in low-and middle-income countries: A pragmatic scoping review. J Glob Health. 2022;12:10013. DOI: https://doi.org/10.7189/jogh.12.10013
12: Karim R, Afridi J, Lala G, Yar S, Zaman M, Afrid B. Clinical findings and radiological evaluation of WHO-defined severe pneumonia among hospitalized children. Cureus. 2023;15:e33804. DOI: https://doi.org/10.7759/cureus.33804
13: Eastwood J, Maitland-Scott I. Patient Privacy and Integrated Care: The Multidisciplinary Health Care Team. Int J Integr Care. 2020;20(4):13 DOI: https://doi.org/10.5334/ijic.5591
14: Bronchitis symptoms & treatments—illnesses & conditions. (2015). Available at: https://www.nhsinform.scot/illnesses-and-conditions/lungs-and-airways/bronchitis (Accessed August 24, 2022).
15: Malla D, Rathi V, Gomber S, Upreti L. Can lung ultrasound differentiate between bacterial and viral pneumonia in children? J Clin Ultrasound. 2021;49:91-100. DOI: https://doi.org/10.1002/jcu.22951
16: Raju S, Siddharthan T, McCormack MC. Indoor air pollution and respiratory health. Clin Chest Med. (2020) 41(4):825–43. DOI: https://doi.org/10.1016/j.ccm.2020.08.014
17: Marangu D, Zar HJ. Childhood pneumonia in low-and-middle-income countries: An update. Paediatr Respir Rev. 2019;32:3-9. doi: 10.1016/j.prrv.2019.06.001 DOI: https://doi.org/10.1016/j.prrv.2019.06.001
18: Ma X, Gao W, An J. Clinical effect of reduning combined with gamma globulin treatment on symptom improvement serum levels of IL-6, 25-(OH)D and LDH in children with severe mycoplasma pneumonia. Pak J Med Sci. 2022;38(4Part-II):826-832. doi: 10.12669/pjms.38.4.5203 DOI: https://doi.org/10.12669/pjms.38.4.5203
19: Han R, Yu Q, Zhang G, Li B, Han S, Li G. Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children. Pak J Med Sci. 2020;36(2):156-159. doi: 10.12669/pjms.36.2.1441 DOI: https://doi.org/10.12669/pjms.36.2.1441
20: Same RG, Amoah J, Hsu AJ, Hersh AL, Sklansky DJ, Cosgrove SE, et al. The Association of Antibiotic Duration with Successful Treatment of Community-Acquired Pneumonia in Children. J Pediatric Infect Dis Soc. 2021;10(3):267-273. doi: 10.1093/jpids/piaa055 DOI: https://doi.org/10.1093/jpids/piaa055
Downloads
Published
Issue
Section
License
Copyright (c) 2024 dr zakir ullah (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
